Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has announced an update on its share buy-back program, with 1,000 ordinary shares purchased on the previous day, adding to a total of 33,505 shares bought back to date. The buy-back is part of an ongoing market strategy, as detailed in the company’s latest ASX notification.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
